ProfileGDS4718 / 213706_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 52% 43% 53% 50% 53% 62% 53% 37% 49% 46% 37% 58% 59% 57% 47% 47% 46% 57% 48% 49% 50% 48% 47% 47% 53% 46% 45% 38% 56% 46% 49% 50% 47% 46% 54% 57% 47% 50% 60% 47% 55% 49% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6567652
GSM549102patient 115, normal, homogenized [OPG study]5.6777652
GSM549104patient 119, normal, homogenized [OPG study]5.1329743
GSM549108patient 138, normal, homogenized [OPG study]5.7160953
GSM549119patient 077, normal, homogenized [OPG study]5.5490550
GSM549133patient 032, cancer, homogenized [OPG study]5.6360753
GSM549139patient 042, cancer, homogenized [OPG study]6.2341262
GSM549099patient 107, normal, homogenized [OPG study]5.6629153
GSM549109patient 139, normal, homogenized [OPG study]4.8823737
GSM549110patient 046, normal, homogenized [OPG study]5.4618949
GSM549114patient 063, normal, homogenized [OPG study]5.2677246
GSM549122patient 082, normal, homogenized [OPG study]4.8421837
GSM549134patient 033, cancer, homogenized [OPG study]5.9557858
GSM549136patient 036, cancer, homogenized [OPG study]6.0284959
GSM549140patient 044, cancer, homogenized [OPG study]5.9257957
GSM549111patient 047, normal, homogenized [OPG study]5.3379347
GSM549113patient 057, normal, homogenized [OPG study]5.2815247
GSM549132patient 031, cancer, homogenized [OPG study]5.2991746
GSM549137patient 038, cancer, homogenized [OPG study]5.9431657
GSM549142patient 047, cancer, homogenized [OPG study]5.5152248
GSM549100patient 110, normal, homogenized [OPG study]5.4477449
GSM549107patient 135, normal, homogenized [OPG study]5.503550
GSM549115patient 068, normal, homogenized [OPG study]5.3400548
GSM549116patient 072, normal, homogenized [OPG study]5.3400247
GSM549120patient 078, normal, homogenized [OPG study]5.3366947
GSM549131patient 030, cancer, homogenized [OPG study]5.6230553
GSM549118patient 074, normal, homogenized [OPG study]5.3101146
GSM549129patient 027, cancer, homogenized [OPG study]5.2536345
GSM549123patient 088, normal, homogenized [OPG study]4.8881138
GSM549124patient 006, cancer, homogenized [OPG study]5.9158656
GSM549126patient 015, cancer, homogenized [OPG study]5.2665746
GSM549128patient 025, cancer, homogenized [OPG study]5.4177249
GSM549103patient 117, normal, homogenized [OPG study]5.5495950
GSM549117patient 073, normal, homogenized [OPG study]5.3296847
GSM549138patient 041, cancer, homogenized [OPG study]5.2680746
GSM549141patient 045, cancer, homogenized [OPG study]5.6979454
GSM549130patient 028, cancer, homogenized [OPG study]5.9049957
GSM549101patient 111, normal, homogenized [OPG study]5.3625647
GSM549105patient 128, normal, homogenized [OPG study]5.5540950
GSM549106patient 134, normal, homogenized [OPG study]6.1293960
GSM549112patient 048, normal, homogenized [OPG study]5.3323747
GSM549125patient 011, cancer, homogenized [OPG study]5.7857255
GSM549127patient 024, cancer, homogenized [OPG study]5.470249
GSM549135patient 035, cancer, homogenized [OPG study]5.5905252